Zoon; Kathryn C.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Zoon; Kathryn C..The latest application filed is for "synergistic combination of il4 receptor targeted agents, interferon gamma, and interferon alpha for use in treating ovarian canc".
- Zoon; Kathryn C. - Kensington MD
| Patent | Date |
|---|---|
| Synergistic combination of IL-4, interferon gamma, and interferon alpha in treating ovarian cancer Grant 10,849,960 - Puri , et al. December 1, 2 | 2020-12-01 |
| Synergistic Combination Of Il4 Receptor Targeted Agents, Interferon Gamma, And Interferon Alpha For Use In Treating Ovarian Canc App 20200282020 - Puri; Raj K. ; et al. | 2020-09-10 |
| Interferon alpha hybrids Grant 7,235,232 - Zoon , et al. June 26, 2 | 2007-06-26 |
| Interferon .alpha. hybrids Grant 6,685,933 - Zoon , et al. February 3, 2 | 2004-02-03 |
| Interferon alpha hybrids App 20040018172 - Zoon, Kathryn C. ; et al. | 2004-01-29 |
| SEC | 0001685720 | Zoon Kathryn C |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 